The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
Volume 336:741-746 March 13, 1997 Number 11
NextNext

Acute Non-A–E Hepatitis in the United States and the Role of Hepatitis G Virus Infection
Miriam J. Alter, Ph.D., Margaret Gallagher, Ph.D., Timothy T. Morris, B.S., Linda A. Moyer, B.A., Emory L. Meeks, B.S., Krzysztof Krawczynski, M.D., Ph.D., Jungsuh P. Kim, Ph.D., Harold S. Margolis, M.D., for The Sentinel Counties Viral Hepatitis Study Team

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background Little is known about the relation of the newly discovered hepatitis G virus (HGV) to the cause and clinical course of acute and chronic viral hepatitis.

Methods We selected patients from a surveillance study of acute viral hepatitis in four U.S. counties who had acute disease during 1985 to 1986 or 1991 to 1995. Serum samples were tested for HGV RNA by the polymerase chain reaction.

Results HGV RNA was detected in 4 of 45 patients with a diagnosis of non-A–E hepatitis (9 percent), 23 of 116 patients with hepatitis C (20 percent), 25 of 100 patients with hepatitis A (25 percent), and 32 of 100 patients with hepatitis B (32 percent) (P<0.05 for the comparison of hepatitis B with hepatitis non-A–E or C). The clinical characteristics of the acute illness were similar for patients with HGV alone and those with hepatitis A, B, or C with or without HGV infection. During a follow-up period of one to nine years, chronic hepatitis did not develop in any of the patients with HGV alone, but 75 percent were persistently positive for HGV RNA, as were 87 percent of those with both hepatitis C and HGV infection. The rates of chronic hepatitis were similar in patients with hepatitis C alone (60 percent) and those with both hepatitis C and HGV infection (61 percent).

Conclusions The evidence from this surveillance study does not implicate HGV as an etiologic agent of non-A–E hepatitis. Persistent infection with HGV was common, but it did not lead to chronic disease and did not affect the clinical course in patients with hepatitis A, B, or C.


Source Information

From the Hepatitis Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta (M.J.A., M.G., T.T.M., L.A.M., E.L.M., K.K., H.S.M.); and Genelabs Technologies, Redwood City, Calif. (J.P.K.).

Address reprint requests to Dr. Alter at the Hepatitis Branch, Mailstop G37, Centers for Disease Control and Prevention, Atlanta, GA 30333.

Full Text of this Article


Related Letters:

Hepatitis G Infection
Kudo T., Morishima T., Shibata M., Goedert J. J., Steinmeyer L. A., Nakatsuji Y.
Extract | Full Text  
N Engl J Med 1997; 337:276-277, Jul 24, 1997. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.